RedHill Biopharma (RDHL) Prepaid Assets (2011 - 2025)
RedHill Biopharma (RDHL) reported Prepaid Assets of $2.5 million for Q4 2025, up 124.46% year-over-year from $1.1 million in Q4 2024, and up 145.35% quarter-over-quarter from $1.0 million in Q2 2025.
RedHill Biopharma (RDHL) Prepaid Assets (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has 15 years of Prepaid Assets data on file, last reported at $2.5 million in Q4 2025.
- Prepaid Assets for Q4 2025 came in at $2.5 million, up 124.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (up 124.46% YoY), and the FY2025 annual result was $2.5 million, up 124.46% from the prior year.
- Prepaid Assets advanced to $2.5 million in Q4 2025 per RDHL's latest filing, from $1.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.2 million in Q1 2023 and troughed at $1.0 million in Q2 2025.
- A 5-year average of $3.3 million and a median of $3.3 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2025: Prepaid Assets soared 155.24% in 2021, then plunged 65.28% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $4.7 million in 2021, then retreated by 5.88% to $4.4 million in 2022, then slumped by 36.15% to $2.8 million in 2023, then slumped by 60.59% to $1.1 million in 2024, then surged by 124.46% to $2.5 million in 2025.
- Business Quant data shows RDHL's Prepaid Assets at $2.5 million in Q4 2025, $1.0 million in Q2 2025, and $1.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.48 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 5.17 Mn |
| Dec 31, 2022 | 4.39 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 4.66 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Mar 31, 2021 | 4.09 Mn |
| Dec 31, 2020 | 5.52 Mn |
| Sep 30, 2020 | 4.64 Mn |
| Jun 30, 2020 | 4.87 Mn |
| Mar 31, 2020 | 1.60 Mn |
| Dec 31, 2019 | 2.24 Mn |